Healthcare

The most recent verified trigger for renewed attention was a preliminary results release in early July 2026. On around 10 July 2026, Mesoblast reported unaudited figures showing Ryoncil net revenue of approximately US$36 million for the fourth quarter ended 30 June 2026 and roughly …

The renewed focus on Race Oncology reflects an accumulation of developments through late 2025 and the first half of 2026 rather than a single event. Over that period the company secured a human research ethics approval for a lung cancer study, expanded its clinical …

The ASX Health Care Index (XHJ) traded lower during delayed intraday trading on 22 July 2026, falling approximately 1.08% to around 42,987.60. The decline came as investors favoured mining, gold and energy companies, leaving healthcare among the weaker-performing sectors. Although the movement attracted market …

Paragon Care Limited (ASX: PGC) traded lower during delayed intraday trading on 22 July 2026, with its shares declining approximately 3.70% to around AUD 0.13. The decline came as healthcare stocks broadly underperformed the Australian market, while mining and commodity-related sectors attracted stronger investor …

Imricor Medical Systems Inc. (ASX: IMR) traded lower during delayed intraday trading on 22 July 2026, with its shares easing approximately 3.18% to around AUD 1.68. The decline came as healthcare stocks broadly underperformed the Australian sharemarket, while resource-related sectors attracted stronger investor demand. …

Botanix Pharmaceuticals Limited (ASX: BOT) traded lower during delayed intraday trading on 22 July 2026 as selling pressure weighed on healthcare stocks across the Australian market. The decline occurred despite broader gains in resource-related sectors, with investors favouring mining and commodity-linked companies over several …

Saluda Medical, Inc. (ASX: SLD) traded lower during delayed intraday trading on 22 July 2026, with its shares easing approximately 3.81% to around AUD 0.51. The decline occurred as healthcare stocks broadly underperformed the Australian sharemarket, while resource-related sectors attracted stronger investor demand. Although …